Canton Strategic Holdings (CNTN) Non-cash Items (2021 - 2026)
Canton Strategic Holdings (CNTN) reported Non-cash Items of $656163.0 for Q1 2026, up 215.29% on a YoY basis from $208111.0 in Q1 2025, and little changed quarter-over-quarter from $657042.0 in Q4 2025.
Canton Strategic Holdings (CNTN) Non-cash Items (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Non-cash Items for 5 years, with the latest figure at $656163.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 215.29% year-over-year to $656163.0; the trailing twelve-month figure through Mar 2026 stood at $656163.0 (up 215.29% YoY), and the FY2025 full-year result was $657042.0, changed N/A from the prior year.
- Non-cash Items for Q1 2026 stood at $656163.0, roughly flat from $657042.0 in the prior quarter.
- The five-year high for Non-cash Items was $823597.0 in Q1 2022, with the low at $5323.0 in Q2 2024.
- Historically, Non-cash Items has averaged $402362.9 across 4 years, with a median of $423037.5 in 2025.
- Annual changes were most pronounced in 2025 — Non-cash Items surged 4390.57% — and 2026, when it soared 215.29%.
- Canton Strategic Holdings' Non-cash Items stood at $823597.0 in 2022, then tumbled by 97.26% to $22592.0 in 2024, then soared by 2808.29% to $657042.0 in 2025, then fell by 0.13% to $656163.0 in 2026.
- The last three Non-cash Items figures came in at $656163.0 (Q1 2026), $657042.0 (Q4 2025), and $607042.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 656,163.00 |
| Mar 31, 2026 | 656,163.00 |
| Dec 31, 2025 | 657,042.00 |
| Dec 31, 2025 | 657,042.00 |
| Sep 30, 2025 | 607,042.00 |
| Sep 30, 2025 | 607,042.00 |
| Jun 30, 2025 | 239,033.00 |
| Jun 30, 2025 | 239,033.00 |
| Mar 31, 2025 | 208,111.00 |
| Mar 31, 2025 | 208,111.00 |
| Sep 30, 2024 | 22,592.00 |
| Sep 30, 2024 | 22,592.00 |
| Jun 30, 2024 | 5,323.00 |
| Jun 30, 2024 | 5,323.00 |
| Mar 31, 2022 | 823,597.00 |
| Mar 31, 2022 | 823,597.00 |
| Dec 31, 2021 | 580,642.00 |
| Dec 31, 2021 | 580,642.00 |